Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium
- PMID: 7553855
- DOI: 10.1016/0092-8674(95)90274-0
Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium
Abstract
Batten disease (also known as juvenile neuronal ceroid lipofuscinosis) is a recessively inherited neurodegenerative disorder of childhood characterized by progressive loss of vision, seizures, and psychomotor disturbances. The Batten disease gene, CLN3, maps to chromosome 16p12.1. The so-called 56 chromosome haplotype defined by alleles at the D16S299 and D16S298 loci is shared by 73% of Batten disease chromosomes. Exon amplification of a cosmid containing D16S298 has yielded a candidate gene that is disrupted by a 1 kb genomic deletion in all patients carrying the 56 chromosome. Two separate deletions and a point mutation altering a splice site in three unrelated families have confirmed the candidate as the CLN3 gene. The disease gene encodes a novel 438 amino acid protein of unknown function.
Similar articles
-
Chromosome 16 microdeletion in a patient with juvenile neuronal ceroid lipofuscinosis (Batten disease).Am J Hum Genet. 1995 Mar;56(3):663-8. Am J Hum Genet. 1995. PMID: 7887420 Free PMC article.
-
YAC and cosmid contigs spanning the Batten disease (CLN3) region at 16p12.1-p11.2.Genomics. 1995 Sep 20;29(2):478-89. doi: 10.1006/geno.1995.9978. Genomics. 1995. PMID: 8666398
-
Fine genetic mapping of the Batten disease locus (CLN3) by haplotype analysis and demonstration of allelic association with chromosome 16p microsatellite loci.Genomics. 1993 May;16(2):455-60. doi: 10.1006/geno.1993.1210. Genomics. 1993. PMID: 8314582
-
Phenol sulfotransferases: candidate genes for Batten disease.Am J Med Genet. 1995 Jun 5;57(2):327-32. doi: 10.1002/ajmg.1320570245. Am J Med Genet. 1995. PMID: 7668357 Review.
-
Genetic analysis of Batten disease.J Inherit Metab Dis. 1993;16(4):787-90. doi: 10.1007/BF00711910. J Inherit Metab Dis. 1993. PMID: 8412021 Review.
Cited by
-
Sex differences in gene expression with galactosylceramide treatment in Cln3Δex7/8 mice.PLoS One. 2020 Oct 2;15(10):e0239537. doi: 10.1371/journal.pone.0239537. eCollection 2020. PLoS One. 2020. PMID: 33006978 Free PMC article.
-
Full-field electroretinography - when do we need it?Saudi J Ophthalmol. 2023 Oct 24;37(4):263-268. doi: 10.4103/sjopt.sjopt_126_23. eCollection 2023 Oct-Dec. Saudi J Ophthalmol. 2023. PMID: 38155681 Free PMC article.
-
Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.J Biol Chem. 2015 Jun 5;290(23):14361-80. doi: 10.1074/jbc.M114.621706. Epub 2015 Apr 15. J Biol Chem. 2015. PMID: 25878248 Free PMC article.
-
Neuronal ceroid lipofuscinosis type CLN2: a new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America.Gene. 2013 Mar 1;516(1):114-21. doi: 10.1016/j.gene.2012.12.058. Epub 2012 Dec 22. Gene. 2013. PMID: 23266810 Free PMC article.
-
Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.J Inherit Metab Dis. 2005;28(6):1065-80. doi: 10.1007/s10545-005-0125-7. J Inherit Metab Dis. 2005. PMID: 16435200
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
